Professor
Department of Neuroscience & Regenerative Medicine
Department of Neuroscience & Regenerative Medicine
1120 15th Street, Rm. CA3002
Medical College of Georgia Augusta University
Augusta, GA 30912
Phone: 706-721-0700
E-mail: qiwang@augusta.edu
1992 MD Peking University Health Science Center (Bejing Medical University)
1999 PhD University of Iowa, Ph.D. in Molecular Biology
2000-2002 Postdoctoral Fellow, Vanderbilt University, Department of Pharmacology
We are a highly motivated group of scientists doing translational neuropharmacology research. Our lab is interested in receptor neuropharmacology and synaptic signaling of neurotransmitters and hormones under normal and disease conditions. We implement a variety of approaches including genetic, cell biological, biochemical, single-cell transcriptomic, proteomic, pharmacological and behavioral approaches. We utilize mouse models, human postmortem tissues and human iPSC-derived brain cells. Our ultimate goal is to discover cures for neuropsychiatric disorders.
Some of our focus are:
1. Molecular and cellular mechanisms underlying Alzheimer’s disease (AD) pathogenesis
a) noradrenergic dysfunction and adrenergic signaling in AD;
b) regulation of endosomal trafficking and its involvement in AD pathogenesis;
c) astrocyte reactivity in AD;
d) tumors and related therapies as risk factors for AD.
2. Cognition and complex behaviors
a) synaptic signaling in autism;
b) epigenetic regulation of anxiety and
c) a novel mouse model for ADHD.
3. Selective targeting of GPCRs
a) neural-specific enhancement of adenosine receptor for neuroprotection;
b) signaling-specific targeting of adrenergic receptor for AD.
Shalini Saggu – Assistant Professor
Hasibur Rehman – Research Scientist
Praveen Korla – Postdoctoral Fellow
Juli Jain - Postdoctoral Fellow
Mae Aida – Research Associate
Amy Trang – Research Associate
Destany Ware - Research Associate
Saggu S, Chen Y, Wang H, Cottingham C, Zhang S, Augelli-Szafran C, Jiao K, Lu X and Wang Q.
(2022) Ligand-selective activation of cofilin leads to distinct regulation of fear memory
reconsolidation by α2AR agonists. Mol Psychiatry. In revision.
Saggu S, Chen Y, Pizarro D, Law W, Pati S, McMahon L, Jiao K and Wang Q (2022)
Peptide blocker of the adenosine A1R-neurabin interaction displays strong anti-seizure
effects and reduces epileptic activities in an Alzheimer’s model. JCI Insight. Jun 8;7(11):e155002.
doi: 10.1172/jci.insight. 155002
Cunningham J, Sheppard LD, Listik E and Wang Q (2022) Self-paced five-choice serial
reaction time-task for mouse behavior testing. bio-101. https://en.bio protocol.org/bio101/
e4388.
Hao X, Li Z, Li W, Katz J, Michalek S, Barnum SR, Pozzo-Miller L, Saito T, Saido T, Wang
Q, Roberson ED, Zhang P. (2022) Periodontal Infection Aggravates C1q-Mediated Microglial
Activation and Synapse Pruning in Alzheimer’s Mice. Frontiers in Immunology. 01 Feb. 2022.
Yan S, Thienthanasit R, Chen D, Engelen E, Bruhl J, Crossman D, Kesterson R, Wang Q,
Bouazoune K, and Jiao K (2020) CHD7 regulates cardiovascular development through ATP–
dependent and -independent activities. Proc Natl Acad Sci, 117:28847-28858.
Zhang Y, Song L, Dong H, Kim D, Sun Z, Boger H, Wang Q and Wang H. (2020)
Spinophilin -deficient mice are protected from diet-induced obesity and insulin resistance.
AJP-Endocrinology and Metabolism. 319: E354–E362.
Kumar SNK, Devarajan A, Karan G, Suresh S, Wang Q, van Groen T, del Monte F,
Rajasekaran NS. (2020) Reductive stress promotes protein aggregation and impairs
neurogenesis. Redox Biol. 37:101739.
Zhang F, Gannon M, Chen Y, Yan S, Zhang S, Feng W, Tao J, Sha B, Liu Z, Saito T, Saido
T, Keene CD, Jiao K, Roberson ED, Xu H, and Wang Q (2020) Amyloid β rewires
norepinephrine signaling to activate the pathogenic GSK3β/tau cascade. Science Transl Med.
Vol. 12, Issue 526, eaay6931.
Gannon M, Wang Q (2019). Complex Noradrenergic Dysfunction in Alzheimer's Disease:
Low Norepinephrine Input is Not Always to Blame. Brain Res. 1702, 12-16.
Yim Y, Betke K, McDonald WH, Gilsbach R, Chen Y, Hyde K, Wang Q, Hein L, and Hamm
H (2019) The in vivo specificity of synaptic Gβ and Gγ subunits to the α2a adrenergic receptor
at CNS synapses. Sci Rep. 9:1718.
Cottingham C, Che P, Zhang W, Wang H, Wang RX, Percival S, Birky T, Zhou L, Jiao K and
Wang Q (2017) Diverse arrestin-recruiting and endocytic profiles of tricyclic antipsychotics
acting as direct a2A adrenergic receptor ligands. Neuropharmacology, 116, 38-49.
Reyes B, Carvalho AF, Szot P, Kalamarides D, Wang Q, Kirby L, Van Bockstaele E (2017)
Cortical adrenoceptor expression, function and adaptation under conditions of cannabinoid
receptor deletion. Exp Neurol., 292, 179-192.
Chen Y, Booth C, Wang H, Wang RX, Terzi D, Zachariou V, Zhang J, Jiao K and Wang Q
(2017) Effective attenuation of adenosine A1R signaling by neurabin requires neurabin
oligomerization. Mol Pharm. 92, 630-639.
Scarduzio M, Zimmerman CN, Jaunarajs KL, Wang Q, Standaert DG and McMahon L
(2017) Elevated striatal cholinergic tone drives dopamine D2 receptor mediated paradoxical
excitation of cholinergic interneurons in DYT1 dystonia. Exp Neurol. 295, 162-175.
Zhang F, Gannon M, Chen Y, Zhou L, Jiao K and Wang Q (2017) The amyloid precursor
protein modulates α2A adrenergic receptor endocytosis and signaling through disrupting
arrestin 3 recruitment. FASEB J. 31, 4434-4446.
Wu H, Cottingham C, Wang H, Che P, Wang RX, Jiao K and Wang Q (2017) Age-
dependent differential regulation of anxiety- and depression-related behaviors by neurabin
and spinophilin. PLoS One. 12(7):e0180638.
Chen Y, Peng Y, Che P, Gannon M, Liu Y, Li L, Bu G, van Groen T, Jiao K and Wang Q
(2014) alpha2A adrenergic receptor promotes amyloidogenesis through disrupting APP-
SorLA interaction. Proc Natl Acad Sci, 111, 17296-17301.
Wang Q, Zhao J, Brady AE, Feng J, Allen PB, Lefkowitz RJ, Greengard P and Limbird LE
(2004) Spinophilin blocks arrestin actions in vitro and in vivo at G protein-coupled receptors.
Science 304, 1940-1944 (Research Article).
We are currently welcoming postdoctoral fellows, graduate students and undergraduate students to join our laboratory.
Postdoctoral Fellows:
We seek postdoctoral fellows interested in studying Alzheimer’s disease. The candidates
will hold a PhD or MD or equivalent in neuroscience, physiology, molecular/cell biology,
biochemistry or neuropharmacology. Expertise in molecular biology and biochemistry
is desirable. Candidates are expected to have good communication skills and have a
strong drive for building a successful research career.
Graduate Students:
We welcome graduate students and are interested in potential rotation students. Prospective
students can apply to our lab through the Graduate Program in Neuroscience as well
as through the MD/PhD Program.
Undergraduate Students and medical students:
We accept motivated undergraduate students and medical students who are interested
in biomedical research.
Dr. Qin Wang will lead new Program for Alzheimer’s Therapeutics Discovery at MCG
Potential drug for Alzheimer's disease could block early damage, MCG researcher says